• 1
    Aigner T, Oehler S, Niedobitek HG, Fassbender G, Kirchner T. Iron deposits, cell populations and proliferative activity in pigmented villonodular synovitis of the knee joint. Verh Dtsch Ges Pathol 1998; 82: 32731.
  • 2
    Fassbender HG. Nodular synovitis. In: FassbenderHG, editor. Pathology and pathobiology of rheumatic diseases. 2nd ed. Heidelberg: Springer; 2002. p. 41724.
  • 3
    Layfield LJ, Meloni-Ehrig A, Liu K, Shepard R, Harrelson JM. Malignant giant cell tumor of synovium (malignant pigmented villonodular synovitis). Arch Pathol Lab Med 2000; 124: 163641.
  • 4
    Weiss SW, Goldblum JR. Benign tumors and tumor-like lesions. In: WeissSW, GoldblumJR, EnzingerFM, editors. Enzinger and Weiss's soft tissue tumors. 4th ed. Berlin: Mosby; 2001. p. 103762.
  • 5
    Sambrook J, Russell DW. Molecular cloning: a laboratory manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2001.
  • 6
    Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD, Eberwine JH. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci U S A 1990; 87: 16637.
  • 7
    Schneider J, Buness A, Huber W, Volz J, Kioschis P, Hafner M, et al. Systematic analysis of T7 RNA polymerase based in vitro linear RNA amplification for use in microarray experiments. BMC Genomics 2004; 5: 29.
  • 8
    Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002; 18 Suppl 1: S96104.
  • 9
    Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001; 98: 511621.
  • 10
    Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 2002; 99: 656772.
  • 11
    Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 2003; 4: R70.
  • 12
    Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al, and the Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat Genet 2000; 25: 259.
  • 13
    Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comp Graph Stat 1996; 5: 299314.
  • 14
    Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
  • 15
    Griffin MC, Robinson RA, Trask DK. Validation of tissue microarrays using p53 immunohistochemical studies of squamous cell carcinoma of the larynx. Mod Pathol 2003; 16: 11818.
  • 16
    Feldmann M, Brennan FM, Foxwell BM, Maini RN. The role of TNFα and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun 2001; 3: 18899.
  • 17
    Naor D, Nedvetzki S. CD44 in rheumatoid arthritis. Arthritis Res Ther 2003; 5: 10515.
  • 18
    Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996; 149: 214351.
  • 19
    Jenson SD, Robetorye RS, Bohling SD, Schumacher JA, Morgan JW, Lim MS, et al. Validation of cDNA microarray gene expression data obtained from linearly amplified RNA. Mol Pathol 2003; 56: 30712.
  • 20
    Rajeevan MS, Vernon SD, Taysavang N, Unger ER. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 2001; 3: 2631.
  • 21
    Rasmussen AM, Blomhoff HK, Stokke T, Horejsi V, Smeland EB. Cross-linking of CD53 promotes activation of resting human B lymphocytes. J Immunol 1994; 153: 49975007.
  • 22
    Rittling SR, Chambers AF. Role of osteopontin in tumour progression. Br J Cancer 2004; 90: 187781.
  • 23
    Kim TR, Yoon JH, Kim YC, Yook YH, Kim IG, Kim YS, et al. LPS-induced CD53 expression: a protection mechanism against oxidative and radiation stress. Mol Cells 2004; 17: 12531.
  • 24
    Yunta M, Lazo PA. Apoptosis protection and survival signal by the CD53 tetraspanin antigen. Oncogene 2003; 22: 121924.
  • 25
    Voehringer DW, Hirschberg DL, Xiao J, Lu Q, Roederer M, Lock CB, et al. Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. Proc Natl Acad Sci U S A 2000; 97: 26805.
  • 26
    Yamamoto N, Sakai F, Kon S, Morimoto J, Kimura C, Yamazaki H, et al. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest 2003; 112: 1818.
  • 27
    Seimiya M, O-Wang J, Bahar R, Kawamura K, Wang Y, Saisho H, et al. Stage-specific expression of Clast6/E3/LAPTM5 during B cell differentiation: elevated expression in human B lymphomas. Int J Oncol 2003; 22: 3014.
  • 28
    Walker MG. Z39Ig is co-expressed with activated macrophage genes. Biochim Biophys Acta 2002; 1574: 38790.
  • 29
    Witke W, Li W, Kwiatkowski DJ, Southwick FS. Comparisons of CapG and gelsolin-null macrophages: demonstration of a unique role for CapG in receptor-mediated ruffling, phagocytosis, and vesicle rocketing. J Cell Biol 2001; 154: 77584.
  • 30
    Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M, et al. Matrix metalloproteinases in arthritic disease. Arthritis Res 2002; 4 Suppl 3: S3949.
  • 31
    Himelstein BP, Canete-Soler R, Bernhard EJ, Dilks DW, Muschel RJ. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis 1994; 14: 24658.
  • 32
    Uchibori M, Nishida Y, Tabata I, Sugiura H, Nakashima H, Yamada Y, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in pigmented villonodular synovitis suggests their potential role for joint destruction. J Rheumatol 2004; 31: 1109.
  • 33
    Datta K, Biswal SS, Xu J, Towndrow KM, Feng X, Kehrer JP. A relationship between 5-lipoxygenase-activating protein and bcl-xL expression in murine pro-B lymphocytic FL5.12 cells. J Biol Chem 1998; 273: 281639.
  • 34
    Sennoune SR, Luo D, Martinez-Zaguilan R. Plasmalemmal vacuolar-type H+-ATPase in cancer biology. Cell Biochem Biophys 2004; 40: 185206.
  • 35
    Matsumoto T, Tsurumoto T. Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laboratory parameters. Clin Exp Rheumatol 2001; 19: 65560.
  • 36
    Dehn H, Hogdall EV, Johansen JS, Jorgensen M, Price PA, Engelholm SA, et al. Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer. Acta Obstet Gynecol Scand 2003; 82: 28793.
  • 37
    Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 2004; 14: 1719.
  • 38
    Tan KO, Tan KM, Chan SL, Yee KS, Bevort M, Ang KC, et al. MAP-1, a novel proapoptotic protein containing a BH3-like motif that associates with Bax through its Bcl-2 homology domains. J Biol Chem 2001; 276: 28027.
  • 39
    Kim AC, Peters LL, Knoll JH, van Huffel C, Ciciotte SL, Kleyn PW, et al. Limatin (LIMAB1), an actin-binding LIM protein, maps to mouse chromosome 19 and human chromosome 10q25, a region frequently deleted in human cancers. Genomics 1997; 46: 2913.
  • 40
    Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE, Yang VW. Identification of Kruppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 2004; 23: 395402.
  • 41
    Hackel PO, Gishizky M, Ullrich A. Mig-6 is a negative regulator of the epidermal growth factor receptor signal. Biol Chem 2001; 382: 164962.
  • 42
    Berger I, Aulmann S, Ehemann V, Helmchen B, Weckauf H. Apoptosis resistance in pigmented villonodular synovitis. Histol Histopathol 2005; 20: 117.
  • 43
    Berger I, Weckauf H, Helmchen B, Ehemann V, Penzel R, Fink B, et al. Rheumatoid arthritis and pigmented villonodular synovitis: comparative analysis of cell polyploidy, cell cycle phases and expression of macrophage and fibroblast markers in proliferating synovial cells. Histopathology 2005; 46: 4907.
  • 44
    Kirkpatrick RB, Emery JG, Connor JR, Dodds R, Lysko PG, Rosenberg M. Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res 1997; 237: 4654.
  • 45
    Jones M, Tussey L, Athanasou N, Jackson DG. Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action. J Biol Chem 2000; 275: 796474.
  • 46
    Wang SP, Krits I, Bai S, Lee BS. Regulation of enhanced vacuolar H+-ATPase expression in macrophages. J Biol Chem 2002; 277: 882734.
  • 47
    Ospelt C, Neidhart M, Gay RE, Gay S. Synovial activation in rheumatoid arthritis. Front Biosci 2004; 9: 232334.
  • 48
    Helmchen B, Weckauf H, Ehemann V, Wittmann I, Meyer-Scholten C, Berger I. Expression pattern of cell cycle-related gene products in synovial stroma and synovial lining in active and quiescent stages of rheumatoid arthritis. Histol Histopathol 2005; 20: 36572.
  • 49
    Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti–tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum 2005; 52: 102030.
  • 50
    Kroot EJ, Kraan MC, Smeets TJ, Maas M, Tak PP, Wouters JM. Tumour necrosis factor α blockade in treatment resistant pigmented villonodular synovitis. Ann Rheum Dis 2005; 64: 4979.